Case C-179/16

DECISION

Title: Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato. Request for a preliminary ruling from the Consiglio di Stato. Reference for a preliminary ruling — Competition — Article 101 TFEU — Agreements, decisions and concerted practices — Medicinal products — Directive 2001/83/EC — Regulation (EC) No 726/2004 — Allegations of risks associated with the use of a medicinal product for a treatment not covered by its marketing authorisation (off-label) — Definition of relevant market — Ancillary restriction — Restriction of competition by object — Exemption. Case C-179/16.
ECLI identifier: ECLI:EU:C:2018:25
Judge-Rapporteur: Fernlund
Type of procedure: Reference for a preliminary ruling
Complementary documents:: Communication published in the Official Journal

Summary

19/03/2018

Title: Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato. Request for a preliminary ruling from the Consiglio di Stato. Reference for a preliminary ruling — Competition — Article 101 TFEU — Agreements, decisions and concerted practices — Medicinal products — Directive 2001/83/EC — Regulation (EC) No 726/2004 — Allegations of risks associated with the use of a medicinal product for a treatment not covered by its marketing authorisation (off-label) — Definition of relevant market — Ancillary restriction — Restriction of competition by object — Exemption. Case C-179/16.
ECLI identifier: ECLI:EU:C:2018:25
Judge-Rapporteur: Fernlund
Type of procedure: Reference for a preliminary ruling

23/01/2018

Title: Opinion of Advocate General Saugmandsgaard Øe delivered on 21 September 2017. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato. Request for a preliminary ruling from the Consiglio di Stato. Reference for a preliminary ruling — Competition — Article 101 TFEU — Agreements, decisions and concerted practices — Medicinal products — Directive 2001/83/EC — Regulation (EC) No 726/2004 — Allegations of risks associated with the use of a medicinal product for a treatment not covered by its marketing authorisation (off-label) — Definition of relevant market — Ancillary restriction — Restriction of competition by object — Exemption. Case C-179/16.
ECLI identifier: ECLI:EU:C:2017:714
Advocate General: Saugmandsgaard Øe

21/09/2017

Title: Case C-179/16: Request for a preliminary ruling from the Consiglio di Stato (Italy) lodged on 25 March 2016 — F. Hoffmann-La Roche AG, La Roche SpA, Novartis AG and Novartis Farma SpA v Autorità Garante della Concorrenza e del Mercato

20/06/2016